# Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial

Study · id `cardio:ct-nct06488105` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06488105](<https://clinicaltrials.gov/study/NCT06488105>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT06488105

Browse, organ or system: Blood vessels; Metabolism  
Browse, condition area: Risk and prevention; Coronary and vascular disease; Diabetes and metabolic disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 130 participants.

## Technical summary

Registry record NCT06488105. Randomized; no masking; primary purpose prevention. Start 2024-08-05 (actual); primary completion 2027-11-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 2
- Enrolled: 130 participants (planned count; ClinicalTrials.gov record NCT06488105, source copy `cardio:ctgov-nct06488105-2026-02-27`, retrieved 2026-10-31)
- Started: 2024-08-05 (actual) (ClinicalTrials.gov record NCT06488105, source copy `cardio:ctgov-nct06488105-2026-02-27`, retrieved 2026-10-31)
- Primary completion: 2027-11-30 (anticipated) (ClinicalTrials.gov record NCT06488105, source copy `cardio:ctgov-nct06488105-2026-02-27`, retrieved 2026-10-31)
- Completion: 2029-03-31 (anticipated) (ClinicalTrials.gov record NCT06488105, source copy `cardio:ctgov-nct06488105-2026-02-27`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT06488105, source copy `cardio:ctgov-nct06488105-2026-02-27`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06488105-2026-02-27`, retrieved 2026-10-31)

## The registry's words

- Brief title: Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial
- Acronym: EMERALD RCT
- Condition: Lipid Disorder
- Condition: Hypercholesterolemia
- Condition: Cardiovascular Diseases
- Condition: Atherosclerosis
- Intervention (Drug): Statin (rosuvastatin 10 or 40 mg daily, depending on risk)
- Intervention (Behavioral): Healthy Lifestyle Counseling
- Intervention (Other): Outpatient Followup
- Lead sponsor: Wake Forest University Health Sciences
- Lead sponsor class: OTHER
- Collaborator: National Institutes of Health (NIH)
- Collaborator class: NIH
- Collaborator: National Heart, Lung, and Blood Institute (NHLBI)
- Collaborator class: NIH

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry condition terms include this condition: High cholesterol (hypercholesterolemia) (`cardio:hypercholesterolemia`)
- Registry lists this organization as the lead sponsor: Wake Forest University Health Sciences (`cardio:wake-forest-health-sciences`)
- Registry lists this organization as a collaborator: National Institutes of Health (`cardio:nih`)
- Registry lists this organization as a collaborator: National Heart, Lung, and Blood Institute (`cardio:nhlbi`)

## Provenance

Content hash: af750d96293d700417f9bd87cd04f1dfee597532600fe4ed27beebd1ccedbb62
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
